Location History:
- Combs la Ville, FR (2002 - 2013)
- Paris, FR (2014 - 2016)
Company Filing History:
3 out of 377 
2 out of 1,454 
1 out of 1 
Years Active: 2002-2016
Title: Patricia Vrignaud: Innovator in Antitumor Therapies
Introduction
Patricia Vrignaud is a notable inventor based in Combs la Ville, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor therapies. With a total of 6 patents to her name, her work has had a profound impact on cancer treatment.
Latest Patents
Among her latest patents are innovative pharmaceutical compositions that combine antibodies specifically recognizing CD38 with various chemotherapeutic agents. One of her notable patents is for antitumor combinations containing antibodies recognizing specifically CD38 and melphalan. Another significant patent involves a pharmaceutical composition comprising an antibody specifically recognizing CD38 and vincristine. These advancements showcase her commitment to improving cancer therapies.
Career Highlights
Throughout her career, Patricia has worked with prominent companies in the pharmaceutical industry. She has been associated with Aventis Pharma S.A. and Sanofi, where she has contributed her expertise in drug development and innovation. Her work in these organizations has helped pave the way for new treatment options for patients.
Collaborations
Patricia has collaborated with esteemed colleagues in her field, including Marie-Christine Bissery and Marielle Chiron-Blondel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Patricia Vrignaud's contributions to the field of pharmaceuticals, particularly in antitumor therapies, highlight her role as a leading inventor. Her patents and collaborations reflect her dedication to advancing cancer treatment and improving patient outcomes.